News
September 11, 2007 – Improving how healthcare providers follow proven protocols could reduce the risks of subsequent ...
September 10, 2007
Feature | Maureen Leahy-Patano
When it comes to diagnosing disease, image is everything. It is difficult to treat what you can’t see. That’s especially true in the cardiac cath lab where cardiologists performing procedures ranging from simple diagnostic tests to more complex interventional maneuvers rely on imaging technology to guide their course.
September 10, 2007
Feature
Of the 1. 57 million annual hospital admissions in the U.S. for acute coronary syndromes, 1.24 million are due to unstable angina and non-ST-segment elevation myocardial infarction (UA/NSTEMI).
September 10, 2007Sponsored Content
Feature | Cardiac Imaging
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
March 13, 2026News
September 11, 2007 - The Certification Commission for Healthcare Information Technology (CCHIT) and the MITRE Corp ...
September 10, 2007
Feature | Mary Beth Massat
Since the introduction of the 64 multi-slice CT scanner, studies have examined the utility of this technology for diagnosing coronary artery disease (CAD), and cardiologists are rapidly adopting this technology to perform CT Angiography (CTA) for detecting CAD.
September 10, 2007News
September 11, 2007 - Terumo Interventional Systems announces the launch of its breakthrough Runthrough NS Coronary ...
September 10, 2007Sponsored Content
Feature | Nuclear Imaging
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
November 12, 2025
Feature | Peter Fail, M.D.
More than ever before, cardiologists are adopting CT as the new standard for cardiac care. In the last five years, CT’s popularity as a diagnostic tool has exploded. Its ability to produce slices as thin as 0.5 mm creates a platform for evaluating patients, detecting disease at early stages and designing treatment roadmaps.
September 10, 2007News
September 11, 2007 - CellCyte Genetics Corp. has entered into a collaborative research agreement with physician scientists at the Cleveland Clinic Foundation to investigate the presence and regulation of heart receptors involved in stem cell trafficking in normal and diseased human hearts, using CellCyte's proprietary compounds, with the goal of increasing volumes of stem cells delivered.
September 10, 2007
Feature | Melissa Allen
New York’s Mount Sinai Heart has it all: a star-studded line-up of internationally renowned physicians, scientists and educators, cutting-edge research and unparalleled clinical services. Their secret to success — an integrated approach to cardiovascular healthcare that makes it all possible.
September 10, 2007Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025Feature | Cristen C. Bolan
Just when drug-eluting stents (DES) were going to revolutionize interventional cardiology, new reports that DES may be associated with increased risk of late-stent thrombosis have many physicians putting the brakes on DES use. Despite this significant bump in the road, stent manufacturers are forging ahead with clinical trials on novel systems and on plans to roll out new DES platforms in 2008.
September 09, 2007News
September 10, 2007 - Four analyses of three-year follow-up data that were presented at the ESC Congress 2007 showed that ...
September 09, 2007News
September 7, 2007 - Gary Ansel, M.D., Riverside Methodist Hospital, successfully implanted the GORE VIABAHN ...
September 09, 2007Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Feature | Melissa Allen
According to the Centers for Disease Control and Prevention, more than 70 million Americans currently live with ...
September 09, 2007News
September 6, 2007 — ProSolv CardioVascular, a FUJIFILM company (ProSolv), announced at the 12th Annual Scientific ...
September 09, 2007News
September 10, 2007 - Signalife launched the sales of its new, FDA-approved, ambulatory 12-lead ECG cardiovascular ...
September 09, 2007